コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 outbreaks had a higher proportion of patient ventilatory failure.
2 and will be helpful in assessing the risk of ventilatory failure.
3 es, and support the patient with progressive ventilatory failure.
4 l mechanical ventilation in the treatment of ventilatory failure.
5 reduce the number of infants progressing to ventilatory failure.
6 developed progressive muscular hypotonia and ventilatory failure.
7 % in nine patients with non-COPD hypercapnic ventilatory failure, 77% in 13 post-extubation respirato
8 ghing as needed, patients with neuromuscular ventilatory failure and no ventilator-free breathing abi
10 hip between tests of RMS and the presence of ventilatory failure, defined as a carbon dioxide tension
11 s the impact of tachypnea as an indicator of ventilatory failure during a room air-5 cm H2O continuou
12 may play a major role in the pathogenesis of ventilatory failure; however, recovery from LFF is not w
14 ve pressure modes and their role in managing ventilatory failure in neuromuscular diseases and other
16 r intubation for patients with neuromuscular ventilatory failure in the absence of significant lung d
17 mulation (CMS P(di)) to identify the risk of ventilatory failure in the whole group and in subgroups
19 tion (OR, 11.3; 95% CI, 7.4-17.1; P < .001), ventilatory failure (OR, 12.4; 95% CI, 8.2-18.8; P < .00
20 io [OR], 17.1; 95% CI, 13.8-21.3; P < .001), ventilatory failure (OR, 15.9; 95% CI, 12.8-19.8; P < .0
21 tients were matched for diagnosis of asthma, ventilatory failure, ventilator mode and settings, and e
22 Four of ten patients who presented in acute ventilatory failure were managed without intubation, des